Plasma levels of tumor necrosis factor-alpha (TNF-α), TNF-α soluble receptor type 1 (sTNFR I) and IL-22 in human leishmaniasis

被引:0
|
作者
Rostami, Nateghi M. [1 ]
Jasbi, Seyyedan E. [2 ]
Khamesipour, A. [3 ]
Mohammadi, Miramin A. [3 ]
机构
[1] Qom Univ Med Sci, Fac Med, Dept Microbiol & Immunol, Qom, Iran
[2] Islamic Azad Univ, Qom Branch, Dept Microbiol, Qom, Iran
[3] Univ Tehran Med Sci, Ctr Res & Training Skin Dis & Leprosy, Tehran, Iran
关键词
T-CELL SUBSETS; CUTANEOUS LEISHMANIASIS; INTERFERON-GAMMA; LESION SIZE; PHAGOCYTOSIS; RESPONSES; DISTINCT;
D O I
暂无
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The role of pro-inammatory cytokine tumor necrosis factor-alpha (TNF-alpha) in human leishmaniasis is not fully understood. We analyzed the alterations in the plasma levels of TNF-alpha, soluble TNF receptor type 1 (sTNFR I), IL-17 and IL-22 in the volunteers with leishmaniasis. Blood samples were collected from patients with active cutaneous leishmaniasis (CL), the same CL patients after standard antimonial therapy as healed CL, active visceral leishmaniasis (VL) and healed VL volunteers. Levels of the cytokines were titrated on plasma samples by sandwich ELISA method. The mean level of TNF-alpha was significantly higher in active CL patients than healthy controls (P<0.001) and significantly reduced after treatment in the same volunteers (P<0.001). The mean level of sTNFR I was significantly higher in active CL patients than healthy controls (P<0.05). The mean level of IL-22 in plasma of the AVL patients was significantly higher than that of healthy control group (P<0.05). There is a negative correlation between the levels of TNF-alpha and sTNFR I and healing of CL. Measurement of cytokines in plasma samples is more feasible than cell culture in evaluation of immune response in human leishmaniasis.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 50 条
  • [21] Evaluation of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-1β levels among subjects vaping e-cigarettes and nonsmokers
    Sinha, Dharmendra Kumar
    Vishal
    Kumar, Ashish
    Khan, Mohsin
    Kumari, Ritu
    Kesari, Mritunjay
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (02) : 1072 - 1075
  • [22] Tumour necrosis factor-alpha (TNF-α) gene polymorphisms and narcolepsy
    O'Rourke, CM
    Taylor, CJ
    Shneerson, JM
    Goodman, RS
    GENES AND IMMUNITY, 2003, 4 : S40 - S40
  • [23] Tumor necrosis factor-alpha (TNF-α) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-α antagonist
    Suominen, JS
    Wang, YY
    Kaipia, A
    Toppari, J
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (05) : 629 - 640
  • [24] Inter-relationship between tumour necrosis factor-alpha (TNF-α) and TNF soluble receptors in pulmonary sarcoidosis
    Armstrong, L
    Foley, NM
    Millar, AB
    THORAX, 1999, 54 (06) : 524 - 530
  • [25] The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
    Jang, Dan-in
    Lee, A-Hyeon
    Shin, Hye-Yoon
    Song, Hyo-Ryeong
    Park, Jong-Hwi
    Kang, Tae-Bong
    Lee, Sang-Ryong
    Yang, Seung-Hoon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 16
  • [26] No association between serum levels of tumor necrosis factor-α (TNF-α) or the soluble receptors sTNFR1 and sTNFR2 and breast cancer risk
    Krajcik, RA
    Massardo, S
    Orentreich, N
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (09) : 945 - 946
  • [27] Plasma concentrations of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in patients with anorexia nervosa
    Nakai, Y
    Hamagaki, S
    Takagi, R
    Taniguchi, A
    Kurimoto, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04): : 1226 - 1228
  • [28] Plasma concentrations of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in patients with bulimia nervosa
    Nakai, Y
    Hamagaki, S
    Takagi, R
    Taniguchi, A
    Kurimoto, F
    CLINICAL ENDOCRINOLOGY, 2000, 53 (03) : 383 - 388
  • [29] Inhibition of tumor necrosis factor-α (TNF-α)/TNF-α receptor binding by structural analogues of suramin
    Mancini, F
    Toro, CM
    Mabilia, M
    Giannangeli, M
    Pinza, M
    Milanese, C
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (05) : 851 - 859
  • [30] Effect of tumor necrosis factor-alpha (TNF-α) on erythropoietin induced erythroid cell formation
    Udupa, KB
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 401 - 405